Propoxyphene Hcl And Acetaminophen



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 82.2%
Pain Management 10.2%
Pain 3.0%
Drug Use For Unknown Indication 1.4%
Back Pain 0.5%
Pain In Extremity 0.4%
Arthralgia 0.4%
Procedural Pain 0.3%
Arthritis 0.2%
Musculoskeletal Pain 0.2%
Osteoporosis 0.2%
Toothache 0.2%
Analgesic Therapy 0.1%
Fibromyalgia 0.1%
Gastrooesophageal Reflux Disease 0.1%
Intervertebral Disc Protrusion 0.1%
Osteoarthritis 0.1%
Peptic Ulcer 0.1%
Rheumatoid Arthritis 0.1%
Debridement 0.1%
Cardiovascular Disorder 15.9%
Cardio-respiratory Arrest 15.1%
Myocardial Infarction 13.2%
Cardiac Disorder 12.6%
Arrhythmia 11.4%
Injury 11.4%
Completed Suicide 7.3%
Palpitations 2.4%
Drug Ineffective 1.9%
Dizziness 1.3%
Death 1.1%
Product Quality Issue 1.1%
Cardiac Failure Congestive 0.9%
Tachycardia 0.8%
Chest Pain 0.6%
Heart Rate Increased 0.6%
Multiple Injuries 0.6%
Sudden Death 0.6%
Vomiting 0.6%
Atrial Fibrillation 0.5%
Secondary
Drug Use For Unknown Indication 54.9%
Product Used For Unknown Indication 18.2%
Pain 4.2%
Suicide Attempt 4.2%
Hypertension 2.6%
Analgesia 1.6%
Arrhythmia 1.6%
Essential Hypertension 1.3%
Postoperative Care 1.3%
Arthralgia 1.0%
Epilepsy 1.0%
General Anaesthesia 1.0%
Pain In Extremity 1.0%
Toothache 1.0%
Type 1 Diabetes Mellitus 1.0%
Type 2 Diabetes Mellitus 1.0%
Acute Myeloid Leukaemia 0.8%
Cardiac Disorder 0.8%
Depression 0.8%
Asthma 0.5%
Completed Suicide 26.1%
Respiratory Arrest 14.4%
Death 8.1%
Drug Toxicity 5.4%
Cardio-respiratory Arrest 4.5%
Cardiac Arrest 3.6%
Drug Abuse 3.6%
Intentional Drug Misuse 3.6%
Renal Failure 3.6%
Thrombocytopenia 3.6%
Acute Generalised Exanthematous Pustulosis 2.7%
Pancreatitis Acute 2.7%
Poisoning 2.7%
Pruritus 2.7%
Suicide Attempt 2.7%
Toxicity To Various Agents 2.7%
Hallucination 1.8%
Hyponatraemia 1.8%
Intentional Overdose 1.8%
Palpitations 1.8%
Concomitant
Drug Use For Unknown Indication 25.9%
Pain 15.6%
Product Used For Unknown Indication 12.2%
Depression 4.7%
Hypertension 3.8%
Smoking Cessation Therapy 3.8%
Anxiety 3.4%
Metastases To Bone 3.4%
Insomnia 3.2%
Osteoporosis 3.2%
Prostate Cancer 3.0%
Rheumatoid Arthritis 2.3%
Contraception 2.2%
Osteoarthritis 2.2%
Chest Pain 2.1%
Diabetes Mellitus 1.9%
Gastrooesophageal Reflux Disease 1.9%
Bone Density Decreased 1.8%
Constipation 1.8%
Oral Infection 1.7%
Vomiting 12.5%
Urinary Tract Infection 9.0%
Weight Decreased 7.6%
Williams Syndrome 7.6%
Wound Drainage 7.6%
Pain 6.3%
Tremor 6.3%
Cerebrovascular Accident 4.9%
Deep Vein Thrombosis 3.5%
Injury 3.5%
Renal Failure Acute 3.5%
Thinking Abnormal 3.5%
Urine Output Decreased 3.5%
Viral Infection 3.5%
Weight Increased 3.5%
Cholecystitis Chronic 2.8%
Fatigue 2.8%
International Normalised Ratio Increased 2.8%
Renal Failure 2.8%
Therapeutic Agent Toxicity 2.8%